Archives

Vapotherm® Announces FDA 510(k) Clearance for the All Patient Circuit™, Enabling High Velocity Therapy for Neonatal to Adult Patients

B EXETER, N.H., April 21, 2026 /PRNewswire/ — Vapotherm, Inc., a developer and manufacturer of advanced respiratory technology, today announced it has received 510(k) clearance… Login to continue reading Login…

Read MoreVapotherm® Announces FDA 510(k) Clearance for the All Patient Circuit™, Enabling High Velocity Therapy for Neonatal to Adult Patients

Johnson Controls Announces Second Quarter 2026 Earnings Conference Call Webcast and “Going to Gemba Day” for Investors and Sell-Side Analysts

B CORK, Ireland, April 21, 2026 /PRNewswire/ — Johnson Controls International plc (NYSE: JCI), a global technology leader in energy efficiency, decarbonization, thermal management and… Login to continue reading Login…

Read MoreJohnson Controls Announces Second Quarter 2026 Earnings Conference Call Webcast and “Going to Gemba Day” for Investors and Sell-Side Analysts

Jazz Pharmaceuticals to Present Data at ASCO 2026 Highlighting Advancements for Ziihera® (zanidatamab-hrii) in Gastroesophageal Adenocarcinoma and Zepzelca® (lurbinectedin)

P Rapid oral presentation of PD-L1 subgroup data from HERIZON-GEA-01 evaluating zanidatamab combinations, and additional analyses of tolerability, biomarker response and real-world treatment patterns in… Login to continue reading Login…

Read MoreJazz Pharmaceuticals to Present Data at ASCO 2026 Highlighting Advancements for Ziihera® (zanidatamab-hrii) in Gastroesophageal Adenocarcinoma and Zepzelca® (lurbinectedin)